Soluble AXL as a marker of disease progression and survival in melanoma.
Receptor tyrosine kinase AXL is a one-pass transmembrane protein upregulated in cancers and associated with lower survival and therapy resistance. AXL can be cleaved by the A Disintegrin and Metalloproteinases (ADAM)10 and ADAM17, yielding a soluble version of the protein. Elevated soluble AXL (sAXL...
Main Authors: | Karine Flem-Karlsen, Marta Nyakas, Inger Nina Farstad, Erin McFadden, Patrik Wernhoff, Kari Dolven Jacobsen, Vivi Ann Flørenes, Gunhild Mari Mælandsmo |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0227187 |
Similar Items
-
Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival
by: Slipicevic Ana, et al.
Published: (2012-02-01) -
Ett år og klar for barnehagen? Foreldres forståelser av små barns omsorgsbehov
by: Gunhild R. Farstad, et al.
Published: (2007-05-01) -
Når omsorgsgapet skal dekkes: Islandske foreldres kjønnede omsorgsstrategier
by: Gunhild Regland Farstad
Published: (2012-01-01) -
Axl contributes to efficient migration and invasion of melanoma cells.
by: Hanshuang Shao, et al.
Published: (2023-01-01) -
981 AXL-targeted macrophage phenotype switching mediates checkpoint-resistance in melanoma
by: Jessica Fessler, et al.
Published: (2023-11-01)